For questions about financial assistance,1-844-DUPIXENT, option 1 or
click to learn more
Illustrative image of DUPIXENT mechanism only and not reflective of treatment effect.
Illustrative image of DUPIXENT mechanism only
and not reflective of treatment effect.
Blocks a key source
of inflammation in
the lungs
Not an inhaler, steroid,
or
immunosuppressant
Helps achieve better breathing that lasts
Some people felt
their
asthma
symptoms improve
in as little as 3 days
Discover how DUPIXENT works within the body to target airway inflammation, combat asthma symptoms, and help improve breathing.
Hear real DUPIXENT patients Rachel and Sharron share their struggles with asthma and what led them to DUPIXENT as a treatment option.
It’s time to manage your condition. Use our Find a Specialist tool to look for a pulmonologist or allergist near you.
Sanofi US and Regeneron do not endorse or recommend any particular physician, and search results do not include a comprehensive list of doctors in your area.
Explore DUPIXENT results.
DUPIXENT targets a key source of airway inflammation in your lungs to help prevent asthma attacks and reduce asthma symptoms. DUPIXENT is not a steroid or an inhaler.
Learn more aboutDo not use DUPIXENT if you are allergic to dupilumab or to any of the ingredients in DUPIXENT.
Inactive ingredients: L-arginine hydrochloride, L-histidine, polysorbate 80, sodium acetate, sucrose, and water for injection.
Before using DUPIXENT, tell your doctor about all your medical conditions, including if you:
Tell your doctor about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Especially tell your healthcare provider if you are taking oral, topical, or inhaled corticosteroid medicines or use an asthma medicine. Do not change or stop other medicines, including corticosteroid medicine or other asthma medicine, without talking to your healthcare provider. This may cause other symptoms that were controlled by those medicines to come back.
DUPIXENT was studied in the VENTURE trial, where 86% of patients reduced or eliminated their oral steroid dose with DUPIXENT 300 mg + Standard of Care (SOC) vs 68% with placebo + SOC.
Do not stop taking your corticosteroid medicines unless instructed by your healthcare provider. This may cause other symptoms that were controlled by the corticosteroid medicine to come back.
The most common side effects include injection site reactions, high count of a certain white blood cell (eosinophilia), and pain in the throat (oropharyngeal pain).
View the possible side effects of DUPIXENT in patients with moderate-to-severe eosinophilic or oral corticosteroid–dependent asthma below.
View the possibleDUPIXENT is not an immunosuppressant or a steroid.